← Leaderboards
George R Simon
H. Lee Moffitt Cancer Ctr &Res Inst
$1,836,350
Attributed
$1,836,350
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $362.9K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,836,350 · 2
By mechanism
P50$1,211,496 · 1
R21$624,854 · 1
Top collaborators
No co-investigators on record.
Most similar at H. Lee Moffitt Cancer Ctr &Res Inst
Same institution · by research overlap
- Pearlie K Epling-Burnette$8,114,398
- Tuya Pal$12,373,521
- Javier F Torres-Roca$1,368,698
- Pamela N Munster$9,751,345
Others in their field
Top investigators on “Manuscripts”
- Constance Ann Benson · University Of California, San Diego$122,141,813
- Elizabeth A Thom · George Washington University$101,141,475
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$94,073,024
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$87,365,526
- Steven E Reis · University Of Pittsburgh At Pittsburgh$75,540,768
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,592,133
Research focus
ManuscriptsMolecularMalignant Neoplasm Of LungAbstractingMedicalLogisticsAttentionInvestigationClinical TrialsCommunitiesMalignant NeoplasmsBaseCancer CenterConduct Clinical TrialsConsultationsData AnalysesFollow-UpFrequencies (Time Pattern)Data CollectionDesignEnrollmentEnsureBiostatistics CoreMonitor
Grant awards (6)
CB: Clinical Trials and Biostatistics Core$319,830
P50 · FY2011 · CA · contact PI
CB: Clinical Trials and Biostatistics Core$362,868
P50 · FY2010 · CA · contact PI
CB: Clinical Trials and Biostatistics Core$346,857
P50 · FY2009 · CA · contact PI
CB: Clinical Trials and Biostatistics Core$181,941
P50 · FY2008 · CA · contact PI
Molecular Analysis-Directed Individualised Therapy in Ad$312,427
R21 · FY2005 · CA
Molecular Analysis-Directed Individualised Therapy in Ad$312,427
R21 · FY2004 · CA